Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival.

Source:http://linkedlifedata.com/resource/pubmed/id/16619554

Download in:

View as

General Info

PMID
16619554